Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn's disease: Protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study

Emma Paulides, Mitchell R.K.L. Lie, Christien Janneke Van Der Woude*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)
248 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn's disease: Protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science